跳至主要内容
临床试验/NCT05104528
NCT05104528已完成不适用

Evaluation of Non-Invasive Cardiometry and Ultrasound Guided Inferior Vena Cava Collapsibility Index in Assessing Fluid Responsiveness in Septic Cancer Patients

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2021年9月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
1
主要终点
Inferior vena cava collapsibility index

研究概览

简要总结

43 patients between 18-60 years presenting with criteria of sepsis (life-threatening organ dysfunction caused by a dysregulated host response to infection, suspected or documented infection and an acute increase ≥2 SOFA [Sequential Organ Failure Assessment] points) will be enrolled in our study. Approval of the ethical committee and informed written consent from first degree relatives will be issued. They will be given a full and detailed explanation of the intended study protocol and will be informed about the potential benefits of the development of a successful technique as well as the potential side-effects.

To compare the efficacy of non-invasive cardiometry and ultrasound (US) guided inferior vena cava (IVC) collapsibility when assessing the response of septic patients to fluid therapy guidelines of The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3); in the first six hours of ICU admission .

详细描述

One of the newer non-invasive methods used to assess fluid status has been the IVC collapsibility index (IVC CI) - which has shown encouraging results as a guide to fluid therapy. Studies have shown that there is an increase in CVP and decrease in IVC collapsibility with fluid replacement, as well as that both are affected by changes in intrathoracic pressure and right heart dysfunction.

measurement of (IVC CI) is calculated by ultrasound through maximum IVC diameter - minimum IVC diameter divided by minimum diameter then multiplied by 100.

if it is less than 50% means that the patient is volume non- depleted while if it is more than 50% means the reverse.

The other recent non-invasive monitoring tool is electrical cardiometry. Its idea is based on electrical impedance. The variations in impedance are calculated using an algorithm that allows measurement of the CO as well as other key haemodynamic parameters including preload (Thoracic Fluid Index), afterload (systemic vascular resistance, SVR). This has helped provide a sound guide to each individual patient's response to fluid therapy and selection of the proper cardiovascular medications and support.

To compare the efficacy of non-invasive cardiometry and ultrasound (US) guided inferior vena cava (IVC) collapsibility when assessing the response of septic patients to fluid therapy guidelines of The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3); in the first six hours of ICU admission .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •ASA class I and II
  • •18yrs ≥ Age ≤ 60yrs
  • •Fulfilling criteria of sepsis, as per The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

排除标准

  • •Lack of consent
  • •Active bleeding
  • •Age < 18yrs or > 60yrs
  • •Anticipated surgery or dialysis in the next 8hrs
  • •Aortic regurge
  • •Arrythmias
  • •Cardiac tamponade
  • •Chest wall oedema
  • •Child B and Child C hepatic patients
  • •Congestive heart failure
  • •End-stage kidney disease (ESKD) patients with a creatinine clearance (CrCl) <50ml/min
  • •Massive bilateral pleural effusion
  • •Mechanical ventilation
  • •More than 4hrs after meeting criteria of septic shock
  • •New York Heart Association (NYHA) III and IV cardiac patients
  • •Severe ARDS (acute respiratory distress syndrome)
  • •Tense ascites
  • •Vasopressor infusion (before or after inclusion in the study)

研究组 & 干预措施

Non-invasive cardiometry

Other

OSYPKA Medical ICONTM Noninvasive CardiometerTM Model C3 A technique for the non-invasive determination of SV, CO, cardiac index, stroke index and HR along with other hemodynamic parameters such as preload (Thoracic Fluid Index), afterload and others.

The changes of impedance over time are integrated in a complex algorithm that allows to measure CO and the other above-mentioned parameters.

干预措施: OSYPKA Medical ICONTM Noninvasive CardiometerTM Model C3 (Device)

Non-invasive cardiometry

Other

OSYPKA Medical ICONTM Noninvasive CardiometerTM Model C3 A technique for the non-invasive determination of SV, CO, cardiac index, stroke index and HR along with other hemodynamic parameters such as preload (Thoracic Fluid Index), afterload and others.

The changes of impedance over time are integrated in a complex algorithm that allows to measure CO and the other above-mentioned parameters.

干预措施: Fujifilm Sonosite M-Turbo C Ultrasound system (Device)

结局指标

主要结局

Inferior vena cava collapsibility index

时间窗: 6 hours

The ultrasound guided IVC collapsibility index will be correlated with to the cardiac index determined by the non-invasive cardiometry to determine which is more effective.

次要结局

  • Heart rate(6 hours)
  • Mean Arterial Pressure(6 hours)
  • Central Venous Pressure(6 hours)
  • Lactate clearance(6 hours)
  • Pro-calcitonin(6 hours)
  • Non-invasive cardiometry measurements (cardiac index)(6 hours)
  • Urine Output(6 hours)
  • Inferior Vena Cava Collapsibility Index(6 hours)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Ahmed Abdellatif Hassan Gaafar

Principal Investigator

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验